Venous Thromboembolism in Users of a 24-Day Regimen of a Combined Oral Contraceptive Compared to Conventional 21-Day Regimens: Final Results from the INAS-OC Study

被引：0

作者：

Bardenheuer, Kristina ^{[1
]}

Dinger, Juergen ^{[2
]}

Thai Do Minh ^{[1
]}

机构：

[1] ZEG Berlin Ctr Epidemiol & Hlth Res, Berlin, Germany

[2] Pharmacoepidemiol Consulting, Berlin, Germany

来源：

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2013年 / 22卷

关键词：

D O I：

暂无

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

724

引用

页码：363 / 363

页数：1

共 10 条

[1] The Risk of VTE in Users of a 24-Day Regimen of a Combined Oral Contraceptive Compared to Conventional 21-Day OC Regimens: Results from the INAS-OC Study
Dinger, Juergen
Bardenheuer, Kristina
Franke, Christian
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S131 - S131
[2] THE RISK OF VENOUS THROMBOEMBOLISM IN USERS OF A DROSPIRENONE-CONTAINING ORAL CONTRACEPTIVE WITH A 24-DAY REGIMEN - RESULTS FROM THE INAS-OC STUDY.
Dinger, J.
Bardenheuer, K.
Moehner, S.
FERTILITY AND STERILITY, 2010, 94 (04) : S3 - S3
[3] Cycle Control With a 21-Day Compared With a 24-Day Oral Contraceptive Pill A Randomized Controlled Trial
Kaunitz, Andrew M.
Burkman, Ronald T.
Fisher, Alan C.
LaGuardia, Katherine D.
OBSTETRICS AND GYNECOLOGY, 2009, 114 (06): : 1205 - 1212
[4] Cycle Control With a 21-Day Compared With a 24-Day Oral Contraceptive Pill: A Randomized Controlled Trial
Richman, Susan
OBSTETRICS AND GYNECOLOGY, 2010, 115 (04): : 866 - 867
[5] Bleeding profile of a new 24-day oral contraceptive regimen of norethindrone acetate 1 mg/ethinyl estradiol 20 μg compared to a 21-day regimen.
Ellman, H
Archer, DF
FERTILITY AND STERILITY, 2005, 84 : S171 - S171
[6] Efficacy and safety of a new 24-day oral contraceptive regimen of norethindrone acetate 1 mg/ethinyl estradiol 20 μg given for 24 days compared to a 21-day regimen.
Ellman, H
Archer, DF
FERTILITY AND STERILITY, 2005, 84 : S169 - S170
[7] Effect of 21-day and 24-day oral contraceptive regimens containing gestodene (60 μg) and ethinyl estradiol (15 μg) on ovarian activity
Sullivan, H
Furniss, H
Spona, J
Elstein, M
FERTILITY AND STERILITY, 1999, 72 (01) : 115 - 120
[8] Comparison of a 24-day and a 21-day pill regimen for the novel combined oral contraceptive, nomegestrol acetate and 17β-estradiol (NOMAC/E2): a double-blind, randomized study
Christin-Maitre, S.
Serfaty, D.
Chabbert-Buffet, N.
Ochsenbein, E.
Chassard, D.
Thomas, J. -L.
HUMAN REPRODUCTION, 2011, 26 (06) : 1338 - 1347
[9] Cardiovascular and general safety of a 24-day regimen of drospirenone-containing combined oral contraceptives: final results from the International Active Surveillance Study of Women Taking Oral Contraceptives
Dinger, Juergen
Bardenheuer, Kristina
Heinemann, Klaas
CONTRACEPTION, 2014, 89 (04) : 253 - 263
[10] Incidence of venous thromboembolism in users of combined oral contraceptives in North America and Eastern Europe - Final results from the international active surveillance - Folate and oral contraceptives utilization study (INAS-FOCUS)
Barnett, Clare
Thai Do Minh
Wenger, Christoph
Heinemann, Klaas
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 586 - 586

← 1 →